EU regulator: No more problems with Roche drugs

The European Medicines Agency says it has finished an investigation of the way pharmaceutical giant Roche reported side effects for 19 drugs in the U.S. and has found no new safety concerns.

Last year, the agency took action against Roche after alleging the Swiss drug maker failed to properly report for the medicines, including the Avastin, Herceptin and Xeloda. British authorities said there were "serious shortcomings" in how Roche AG reported potential problems.

In a statement Tuesday, the European regulator said further safety data on the medicines showed "the balance of benefits and risks of these medicines has not been affected and there is no new advice regarding their use." It said Roche continued to provide additional information as part of their obligatory follow-up.


Explore further

Roche probed for not reporting side effects

© 2013 The Associated Press. All rights reserved.

Citation: EU regulator: No more problems with Roche drugs (2013, November 19) retrieved 12 May 2021 from https://medicalxpress.com/news/2013-11-eu-problems-roche-drugs.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments